BRUSSELS, 24th April, 2023 (WAM) - Between 2002 and 2022, EU exports of medicinal and pharmaceutical products to countries outside the EU grew considerably stronger than imports, according to figures published by Eurostat, the statistical office of the European Union.
Exports increased from 50 billion in 2002 to 287 billion in 2022. Compared with 2021 (235 billion), the 2022 total represented an increase of 22%. Imports rose from 32 billion to 112 billion between 2002 to 2022, rising almost 12% from 2021 (100 billion) to 2022.
With extra-EU exports growing more than imports, the EU's trade surplus in medicinal and pharmaceutical products reached 175 billion, the highest value since 2002 (18 billion).
In 2022, Germany was the EU's largest extra-EU exporter (68 billion), followed by Belgium (56 billion), Ireland (42 billion), the Netherlands and Italy (each 22 billion).
The largest extra-EU importers of medicinal and pharmaceutical products were Belgium (21 billion), followed by Germany (19 billion), the Netherlands (18 billion), Spain (10 billion) and Italy (9 billion).
The main destination of extra-EU exports of medicinal and pharmaceutical products in 2022 was the United States, accounting for almost a third (33%) of these exports, followed at a distance by Switzerland (13%), the United Kingdom (7%), China and Japan (both 6%).
Imports of these products to the EU came mainly from the United States, accounting for 35% of all EU imports of these products, then Switzerland (34%), United Kingdom (9%) followed by China (5%) and Singapore (4%).
Regarding trade between the EU and the United States, between 2002 and 2022, EU exports of medicinal and pharmaceutical products grew by more than 9% per year, and EU imports grew by almost 7% per year. During this period, the trade balance has been in favour of the EU, registering a surplus of 54 billion in 2022.
As for Switzerland, between 2002 and 2022, EU exports grew by almost 10% per year, and imports grew by almost 8% per year. Over the same period, the EU had a trade deficit that totalled -8 billion in 2009, 2012, 2019 and -9 billion in 2021. In 2022, a reduction in this deficit was recorded, with the trade balance reported as -1 billion.